Global Nuclear Drug for Therapeutic Market Research Report 2024(Status and Outlook)
Report Overview
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report provides a deep insight into the global Nuclear Drug for Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Drug for Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Drug for Therapeutic market in any manner.
Global Nuclear Drug for Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Drug for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report provides a deep insight into the global Nuclear Drug for Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Drug for Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Drug for Therapeutic market in any manner.
Global Nuclear Drug for Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Drug for Therapeutic Market
- Overview of the regional outlook of the Nuclear Drug for Therapeutic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Drug for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Drug for Therapeutic
1.2 Key Market Segments
1.2.1 Nuclear Drug for Therapeutic Segment by Type
1.2.2 Nuclear Drug for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR DRUG FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Drug for Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Drug for Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Drug for Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Drug for Therapeutic Sales Sites, Area Served, Product Type
3.6 Nuclear Drug for Therapeutic Market Competitive Situation and Trends
3.6.1 Nuclear Drug for Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Drug for Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Drug for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR DRUG FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Drug for Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Drug for Therapeutic Price by Type (2019-2024)
7 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Drug for Therapeutic Market Sales by Application (2019-2024)
7.3 Global Nuclear Drug for Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
8 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.2 Global Nuclear Drug for Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Drug for Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Drug for Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Drug for Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Drug for Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Drug for Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Nuclear Drug for Therapeutic Basic Information
9.1.2 Bayer Nuclear Drug for Therapeutic Product Overview
9.1.3 Bayer Nuclear Drug for Therapeutic Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Nuclear Drug for Therapeutic SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Nuclear Drug for Therapeutic Basic Information
9.2.2 Novartis Nuclear Drug for Therapeutic Product Overview
9.2.3 Novartis Nuclear Drug for Therapeutic Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Nuclear Drug for Therapeutic SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 China Isotope and Radiation
9.3.1 China Isotope and Radiation Nuclear Drug for Therapeutic Basic Information
9.3.2 China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
9.3.3 China Isotope and Radiation Nuclear Drug for Therapeutic Product Market Performance
9.3.4 China Isotope and Radiation Nuclear Drug for Therapeutic SWOT Analysis
9.3.5 China Isotope and Radiation Business Overview
9.3.6 China Isotope and Radiation Recent Developments
9.4 Dongcheng
9.4.1 Dongcheng Nuclear Drug for Therapeutic Basic Information
9.4.2 Dongcheng Nuclear Drug for Therapeutic Product Overview
9.4.3 Dongcheng Nuclear Drug for Therapeutic Product Market Performance
9.4.4 Dongcheng Business Overview
9.4.5 Dongcheng Recent Developments
9.5 Q BioMed
9.5.1 Q BioMed Nuclear Drug for Therapeutic Basic Information
9.5.2 Q BioMed Nuclear Drug for Therapeutic Product Overview
9.5.3 Q BioMed Nuclear Drug for Therapeutic Product Market Performance
9.5.4 Q BioMed Business Overview
9.5.5 Q BioMed Recent Developments
9.6 Curium Pharmaceuticals
9.6.1 Curium Pharmaceuticals Nuclear Drug for Therapeutic Basic Information
9.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
9.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Market Performance
9.6.4 Curium Pharmaceuticals Business Overview
9.6.5 Curium Pharmaceuticals Recent Developments
9.7 Jubilant Radiopharma
9.7.1 Jubilant Radiopharma Nuclear Drug for Therapeutic Basic Information
9.7.2 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
9.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Market Performance
9.7.4 Jubilant Radiopharma Business Overview
9.7.5 Jubilant Radiopharma Recent Developments
9.8 Lantheus
9.8.1 Lantheus Nuclear Drug for Therapeutic Basic Information
9.8.2 Lantheus Nuclear Drug for Therapeutic Product Overview
9.8.3 Lantheus Nuclear Drug for Therapeutic Product Market Performance
9.8.4 Lantheus Business Overview
9.8.5 Lantheus Recent Developments
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Nuclear Drug for Therapeutic Basic Information
9.9.2 Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
9.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Product Market Performance
9.9.4 Aurobindo Pharma Business Overview
9.9.5 Aurobindo Pharma Recent Developments
9.10 International Isotopes
9.10.1 International Isotopes Nuclear Drug for Therapeutic Basic Information
9.10.2 International Isotopes Nuclear Drug for Therapeutic Product Overview
9.10.3 International Isotopes Nuclear Drug for Therapeutic Product Market Performance
9.10.4 International Isotopes Business Overview
9.10.5 International Isotopes Recent Developments
9.11 Mundipharma
9.11.1 Mundipharma Nuclear Drug for Therapeutic Basic Information
9.11.2 Mundipharma Nuclear Drug for Therapeutic Product Overview
9.11.3 Mundipharma Nuclear Drug for Therapeutic Product Market Performance
9.11.4 Mundipharma Business Overview
9.11.5 Mundipharma Recent Developments
10 NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Nuclear Drug for Therapeutic Market Size Forecast
10.2 Global Nuclear Drug for Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Drug for Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region
10.2.4 South America Nuclear Drug for Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Drug for Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Drug for Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Drug for Therapeutic by Type (2025-2030)
11.1.2 Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Drug for Therapeutic by Type (2025-2030)
11.2 Global Nuclear Drug for Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Drug for Therapeutic Sales (Kilotons) Forecast by Application
11.2.2 Global Nuclear Drug for Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Drug for Therapeutic
1.2 Key Market Segments
1.2.1 Nuclear Drug for Therapeutic Segment by Type
1.2.2 Nuclear Drug for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR DRUG FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Drug for Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Drug for Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Drug for Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Drug for Therapeutic Sales Sites, Area Served, Product Type
3.6 Nuclear Drug for Therapeutic Market Competitive Situation and Trends
3.6.1 Nuclear Drug for Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Drug for Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Drug for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR DRUG FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Drug for Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Drug for Therapeutic Price by Type (2019-2024)
7 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Drug for Therapeutic Market Sales by Application (2019-2024)
7.3 Global Nuclear Drug for Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
8 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.2 Global Nuclear Drug for Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Drug for Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Drug for Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Drug for Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Drug for Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Drug for Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Nuclear Drug for Therapeutic Basic Information
9.1.2 Bayer Nuclear Drug for Therapeutic Product Overview
9.1.3 Bayer Nuclear Drug for Therapeutic Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Nuclear Drug for Therapeutic SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Nuclear Drug for Therapeutic Basic Information
9.2.2 Novartis Nuclear Drug for Therapeutic Product Overview
9.2.3 Novartis Nuclear Drug for Therapeutic Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Nuclear Drug for Therapeutic SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 China Isotope and Radiation
9.3.1 China Isotope and Radiation Nuclear Drug for Therapeutic Basic Information
9.3.2 China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
9.3.3 China Isotope and Radiation Nuclear Drug for Therapeutic Product Market Performance
9.3.4 China Isotope and Radiation Nuclear Drug for Therapeutic SWOT Analysis
9.3.5 China Isotope and Radiation Business Overview
9.3.6 China Isotope and Radiation Recent Developments
9.4 Dongcheng
9.4.1 Dongcheng Nuclear Drug for Therapeutic Basic Information
9.4.2 Dongcheng Nuclear Drug for Therapeutic Product Overview
9.4.3 Dongcheng Nuclear Drug for Therapeutic Product Market Performance
9.4.4 Dongcheng Business Overview
9.4.5 Dongcheng Recent Developments
9.5 Q BioMed
9.5.1 Q BioMed Nuclear Drug for Therapeutic Basic Information
9.5.2 Q BioMed Nuclear Drug for Therapeutic Product Overview
9.5.3 Q BioMed Nuclear Drug for Therapeutic Product Market Performance
9.5.4 Q BioMed Business Overview
9.5.5 Q BioMed Recent Developments
9.6 Curium Pharmaceuticals
9.6.1 Curium Pharmaceuticals Nuclear Drug for Therapeutic Basic Information
9.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
9.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Market Performance
9.6.4 Curium Pharmaceuticals Business Overview
9.6.5 Curium Pharmaceuticals Recent Developments
9.7 Jubilant Radiopharma
9.7.1 Jubilant Radiopharma Nuclear Drug for Therapeutic Basic Information
9.7.2 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
9.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Market Performance
9.7.4 Jubilant Radiopharma Business Overview
9.7.5 Jubilant Radiopharma Recent Developments
9.8 Lantheus
9.8.1 Lantheus Nuclear Drug for Therapeutic Basic Information
9.8.2 Lantheus Nuclear Drug for Therapeutic Product Overview
9.8.3 Lantheus Nuclear Drug for Therapeutic Product Market Performance
9.8.4 Lantheus Business Overview
9.8.5 Lantheus Recent Developments
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Nuclear Drug for Therapeutic Basic Information
9.9.2 Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
9.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Product Market Performance
9.9.4 Aurobindo Pharma Business Overview
9.9.5 Aurobindo Pharma Recent Developments
9.10 International Isotopes
9.10.1 International Isotopes Nuclear Drug for Therapeutic Basic Information
9.10.2 International Isotopes Nuclear Drug for Therapeutic Product Overview
9.10.3 International Isotopes Nuclear Drug for Therapeutic Product Market Performance
9.10.4 International Isotopes Business Overview
9.10.5 International Isotopes Recent Developments
9.11 Mundipharma
9.11.1 Mundipharma Nuclear Drug for Therapeutic Basic Information
9.11.2 Mundipharma Nuclear Drug for Therapeutic Product Overview
9.11.3 Mundipharma Nuclear Drug for Therapeutic Product Market Performance
9.11.4 Mundipharma Business Overview
9.11.5 Mundipharma Recent Developments
10 NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Nuclear Drug for Therapeutic Market Size Forecast
10.2 Global Nuclear Drug for Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Drug for Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region
10.2.4 South America Nuclear Drug for Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Drug for Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Drug for Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Drug for Therapeutic by Type (2025-2030)
11.1.2 Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Drug for Therapeutic by Type (2025-2030)
11.2 Global Nuclear Drug for Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Drug for Therapeutic Sales (Kilotons) Forecast by Application
11.2.2 Global Nuclear Drug for Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Drug for Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Nuclear Drug for Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Drug for Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
Table 10. Global Market Nuclear Drug for Therapeutic Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Drug for Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Nuclear Drug for Therapeutic Product Type
Table 13. Global Nuclear Drug for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Drug for Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Drug for Therapeutic Market Challenges
Table 22. Global Nuclear Drug for Therapeutic Sales by Type (Kilotons)
Table 23. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 24. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Type (2019-2024)
Table 25. Global Nuclear Drug for Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Drug for Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Drug for Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Drug for Therapeutic Price (USD/Ton) by Type (2019-2024)
Table 29. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Application
Table 30. Global Nuclear Drug for Therapeutic Market Size by Application
Table 31. Global Nuclear Drug for Therapeutic Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Drug for Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Drug for Therapeutic Market Share by Application (2019-2024)
Table 35. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Nuclear Drug for Therapeutic Basic Information
Table 44. Bayer Nuclear Drug for Therapeutic Product Overview
Table 45. Bayer Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Nuclear Drug for Therapeutic SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Nuclear Drug for Therapeutic Basic Information
Table 50. Novartis Nuclear Drug for Therapeutic Product Overview
Table 51. Novartis Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Nuclear Drug for Therapeutic SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. China Isotope and Radiation Nuclear Drug for Therapeutic Basic Information
Table 56. China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
Table 57. China Isotope and Radiation Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. China Isotope and Radiation Nuclear Drug for Therapeutic SWOT Analysis
Table 59. China Isotope and Radiation Business Overview
Table 60. China Isotope and Radiation Recent Developments
Table 61. Dongcheng Nuclear Drug for Therapeutic Basic Information
Table 62. Dongcheng Nuclear Drug for Therapeutic Product Overview
Table 63. Dongcheng Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Recent Developments
Table 66. Q BioMed Nuclear Drug for Therapeutic Basic Information
Table 67. Q BioMed Nuclear Drug for Therapeutic Product Overview
Table 68. Q BioMed Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Recent Developments
Table 71. Curium Pharmaceuticals Nuclear Drug for Therapeutic Basic Information
Table 72. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
Table 73. Curium Pharmaceuticals Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Recent Developments
Table 76. Jubilant Radiopharma Nuclear Drug for Therapeutic Basic Information
Table 77. Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
Table 78. Jubilant Radiopharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Recent Developments
Table 81. Lantheus Nuclear Drug for Therapeutic Basic Information
Table 82. Lantheus Nuclear Drug for Therapeutic Product Overview
Table 83. Lantheus Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lantheus Business Overview
Table 85. Lantheus Recent Developments
Table 86. Aurobindo Pharma Nuclear Drug for Therapeutic Basic Information
Table 87. Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
Table 88. Aurobindo Pharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Recent Developments
Table 91. International Isotopes Nuclear Drug for Therapeutic Basic Information
Table 92. International Isotopes Nuclear Drug for Therapeutic Product Overview
Table 93. International Isotopes Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Recent Developments
Table 96. Mundipharma Nuclear Drug for Therapeutic Basic Information
Table 97. Mundipharma Nuclear Drug for Therapeutic Product Overview
Table 98. Mundipharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Recent Developments
Table 101. Global Nuclear Drug for Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Nuclear Drug for Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Nuclear Drug for Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Nuclear Drug for Therapeutic Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Nuclear Drug for Therapeutic Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Nuclear Drug for Therapeutic Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Drug for Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Nuclear Drug for Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Drug for Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
Table 10. Global Market Nuclear Drug for Therapeutic Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Drug for Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Nuclear Drug for Therapeutic Product Type
Table 13. Global Nuclear Drug for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Drug for Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Drug for Therapeutic Market Challenges
Table 22. Global Nuclear Drug for Therapeutic Sales by Type (Kilotons)
Table 23. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 24. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Type (2019-2024)
Table 25. Global Nuclear Drug for Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Drug for Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Drug for Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Drug for Therapeutic Price (USD/Ton) by Type (2019-2024)
Table 29. Global Nuclear Drug for Therapeutic Sales (Kilotons) by Application
Table 30. Global Nuclear Drug for Therapeutic Market Size by Application
Table 31. Global Nuclear Drug for Therapeutic Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Drug for Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Drug for Therapeutic Market Share by Application (2019-2024)
Table 35. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Nuclear Drug for Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Nuclear Drug for Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Nuclear Drug for Therapeutic Basic Information
Table 44. Bayer Nuclear Drug for Therapeutic Product Overview
Table 45. Bayer Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Nuclear Drug for Therapeutic SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Nuclear Drug for Therapeutic Basic Information
Table 50. Novartis Nuclear Drug for Therapeutic Product Overview
Table 51. Novartis Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Nuclear Drug for Therapeutic SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. China Isotope and Radiation Nuclear Drug for Therapeutic Basic Information
Table 56. China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
Table 57. China Isotope and Radiation Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. China Isotope and Radiation Nuclear Drug for Therapeutic SWOT Analysis
Table 59. China Isotope and Radiation Business Overview
Table 60. China Isotope and Radiation Recent Developments
Table 61. Dongcheng Nuclear Drug for Therapeutic Basic Information
Table 62. Dongcheng Nuclear Drug for Therapeutic Product Overview
Table 63. Dongcheng Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Recent Developments
Table 66. Q BioMed Nuclear Drug for Therapeutic Basic Information
Table 67. Q BioMed Nuclear Drug for Therapeutic Product Overview
Table 68. Q BioMed Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Recent Developments
Table 71. Curium Pharmaceuticals Nuclear Drug for Therapeutic Basic Information
Table 72. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
Table 73. Curium Pharmaceuticals Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Recent Developments
Table 76. Jubilant Radiopharma Nuclear Drug for Therapeutic Basic Information
Table 77. Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
Table 78. Jubilant Radiopharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Recent Developments
Table 81. Lantheus Nuclear Drug for Therapeutic Basic Information
Table 82. Lantheus Nuclear Drug for Therapeutic Product Overview
Table 83. Lantheus Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lantheus Business Overview
Table 85. Lantheus Recent Developments
Table 86. Aurobindo Pharma Nuclear Drug for Therapeutic Basic Information
Table 87. Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
Table 88. Aurobindo Pharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Recent Developments
Table 91. International Isotopes Nuclear Drug for Therapeutic Basic Information
Table 92. International Isotopes Nuclear Drug for Therapeutic Product Overview
Table 93. International Isotopes Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Recent Developments
Table 96. Mundipharma Nuclear Drug for Therapeutic Basic Information
Table 97. Mundipharma Nuclear Drug for Therapeutic Product Overview
Table 98. Mundipharma Nuclear Drug for Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Recent Developments
Table 101. Global Nuclear Drug for Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Nuclear Drug for Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Nuclear Drug for Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Nuclear Drug for Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Nuclear Drug for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Nuclear Drug for Therapeutic Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Nuclear Drug for Therapeutic Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Nuclear Drug for Therapeutic Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Drug for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Drug for Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Drug for Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Drug for Therapeutic Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Drug for Therapeutic Market Size by Country (M USD)
Figure 11. Nuclear Drug for Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Drug for Therapeutic Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Drug for Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Drug for Therapeutic Market Share by Type
Figure 18. Sales Market Share of Nuclear Drug for Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Drug for Therapeutic by Type in 2023
Figure 20. Market Size Share of Nuclear Drug for Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Drug for Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Drug for Therapeutic Market Share by Application
Figure 24. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Drug for Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Nuclear Drug for Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Nuclear Drug for Therapeutic Market Share by Application in 2023
Figure 28. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Nuclear Drug for Therapeutic Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Drug for Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Nuclear Drug for Therapeutic Sales Market Share by Region in 2023
Figure 44. China Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 50. South America Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Nuclear Drug for Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Nuclear Drug for Therapeutic Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Nuclear Drug for Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Drug for Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Drug for Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Drug for Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Drug for Therapeutic Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Nuclear Drug for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Drug for Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Drug for Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Drug for Therapeutic Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Drug for Therapeutic Market Size by Country (M USD)
Figure 11. Nuclear Drug for Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Drug for Therapeutic Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Drug for Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Drug for Therapeutic Market Share by Type
Figure 18. Sales Market Share of Nuclear Drug for Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Drug for Therapeutic by Type in 2023
Figure 20. Market Size Share of Nuclear Drug for Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Drug for Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Drug for Therapeutic Market Share by Application
Figure 24. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Drug for Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Nuclear Drug for Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Nuclear Drug for Therapeutic Market Share by Application in 2023
Figure 28. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Nuclear Drug for Therapeutic Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Drug for Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Nuclear Drug for Therapeutic Sales Market Share by Region in 2023
Figure 44. China Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 50. South America Nuclear Drug for Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Nuclear Drug for Therapeutic Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Nuclear Drug for Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Nuclear Drug for Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Nuclear Drug for Therapeutic Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Nuclear Drug for Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Drug for Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Drug for Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Drug for Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Drug for Therapeutic Market Share Forecast by Application (2025-2030)
